Great Entry Here
mot going any where this is a keeper- going higher
Wall StreetNetflix Misses U.S. Subscriber Target
RTT News- NFLX Profit Drops 34% in Quarter 4 //// LINK
Netflix Inc. Profit Drops 34% In Q4January 19, 2016, 04:15:00 PM EDT By RTT News
thats how it works in this market
Piper cuts Sarepta to Neutral after removing eteplirsen from model
Piper Jaffray analyst Edward Tenthoff downgraded Sarepta Therapeutics to Neutral from Overweight saying the FDA briefing documents were worse than expected. The FDA's analysis of dystrophin production of only 0.9% of normal was worse than expected and "directly questions" the approvability of eteplirsen,Tenthoff tells investors in a research note. The analyst believes the likelihood of eteplirsen approval is diminished and removed the drug from his model.